pCXWB-EBNA1 Citations (51)
Originally described in: An Efficient Non-viral Method to Generate Integration-Free Human iPS Cells from Cord Blood and Peripheral Blood Cells.Okita K, Yamakawa T, Matsumura Y, Sato Y, Amano N, Watanabe A, Goshima N, Yamanaka S Stem Cells. 2012 Nov 29. doi: 10.1002/stem.1293. PubMed Journal
Articles Citing pCXWB-EBNA1
| Articles |
|---|
| Efficient iPS cell generation from blood using episomes and HDAC inhibitors. Hubbard JJ, Sullivan SK, Mills JA, Hayes BJ, Torok-Storb BJ, Ramakrishnan A. J Vis Exp. 2014 Oct 28;(92):e52009. doi: 10.3791/52009. PubMed |
| Differentiation of blood T cells: Reprogramming human induced pluripotent stem cells into neuronal cells. Tsai PH, Chang YC, Lee YY, Ko YL, Yang YH, Lin CF, Chang YL, Yu WC, Shih YH, Chen MT. J Chin Med Assoc. 2015 Jun;78(6):353-9. doi: 10.1016/j.jcma.2015.03.007. Epub 2015 May 26. PubMed |
| Transgene-Free Disease-Specific iPSC Generation from Fibroblasts and Peripheral Blood Mononuclear Cells. Fidan K, Ebrahimi A, Caglayan OH, Ozcimen B, Onder TT. Methods Mol Biol. 2016;1353:215-31. doi: 10.1007/7651_2015_278. PubMed |
| A Comparative View on Easy to Deploy non-Integrating Methods for Patient-Specific iPSC Production. Manzini S, Viiri LE, Marttila S, Aalto-Setala K. Stem Cell Rev. 2015 Dec;11(6):900-8. doi: 10.1007/s12015-015-9619-3. PubMed |
| Practical Integration-Free Episomal Methods for Generating Human Induced Pluripotent Stem Cells. Kime C, Rand TA, Ivey KN, Srivastava D, Yamanaka S, Tomoda K. Curr Protoc Hum Genet. 2015 Oct 6;87:21.2.1-21.2.21. doi: 10.1002/0471142905.hg2102s87. PubMed |
| Site-specific genome editing for correction of induced pluripotent stem cells derived from dominant dystrophic epidermolysis bullosa. Shinkuma S, Guo Z, Christiano AM. Proc Natl Acad Sci U S A. 2016 May 17;113(20):5676-81. doi: 10.1073/pnas.1512028113. Epub 2016 May 3. PubMed |
| Analysis of DNA topology of EBV minichromosomes in HEK 293 cells. Castan A, Fernandez-Calleja V, Hernandez P, Krimer DB, Schvartzman JB, Fernandez-Nestosa MJ. PLoS One. 2017 Nov 29;12(11):e0188172. doi: 10.1371/journal.pone.0188172. eCollection 2017. PubMed |
| GFAP Mutations in Astrocytes Impair Oligodendrocyte Progenitor Proliferation and Myelination in an hiPSC Model of Alexander Disease. Li L, Tian E, Chen X, Chao J, Klein J, Qu Q, Sun G, Sun G, Huang Y, Warden CD, Ye P, Feng L, Li X, Cui Q, Sultan A, Douvaras P, Fossati V, Sanjana NE, Riggs AD, Shi Y. Cell Stem Cell. 2018 Aug 2;23(2):239-251.e6. doi: 10.1016/j.stem.2018.07.009. PubMed |
| Standards for Deriving Nonhuman Primate-Induced Pluripotent Stem Cells, Neural Stem Cells and Dopaminergic Lineage. Yang G, Hong H, Torres A, Malloy KE, Choudhury GR, Kim J, Daadi MM. Int J Mol Sci. 2018 Sep 17;19(9). pii: ijms19092788. doi: 10.3390/ijms19092788. PubMed |
| MicroRNA characterization in equine induced pluripotent stem cells. Moro LN, Amin G, Furmento V, Waisman A, Garate X, Neiman G, La Greca A, Santin Velazque NL, Luzzani C, Sevlever GE, Vichera G, Miriuka SG. PLoS One. 2018 Dec 3;13(12):e0207074. doi: 10.1371/journal.pone.0207074. eCollection 2018. PubMed |
| Evaluation of commonly used ectoderm markers in iPSC trilineage differentiation. Kuang YL, Munoz A, Nalula G, Santostefano KE, Sanghez V, Sanchez G, Terada N, Mattis AN, Iacovino M, Iribarren C, Krauss RM, Medina MW. Stem Cell Res. 2019 May;37:101434. doi: 10.1016/j.scr.2019.101434. Epub 2019 Apr 10. PubMed |
| Inducible Pluripotent Stem Cell-Derived Cardiomyocytes Reveal Aberrant Extracellular Regulated Kinase 5 and Mitogen-Activated Protein Kinase Kinase 1/2 Signaling Concomitantly Promote Hypertrophic Cardiomyopathy in RAF1-Associated Noonan Syndrome. Jaffre F, Miller CL, Schanzer A, Evans T, Roberts AE, Hahn A, Kontaridis MI. Circulation. 2019 Jul 16;140(3):207-224. doi: 10.1161/CIRCULATIONAHA.118.037227. Epub 2019 Jun 5. PubMed |
| Xeno-Free Reprogramming of Peripheral Blood Mononuclear Erythroblasts on Laminin-521. Skorik C, Mullin NK, Shi M, Zhang Y, Hunter P, Tang Y, Hilton B, Schlaeger TM. Curr Protoc Stem Cell Biol. 2020 Mar;52(1):e103. doi: 10.1002/cpsc.103. PubMed |
| Generation and characterization of a human iPSC line derived from congenital clubfoot amniotic fluid cells. Wang J, Cui Y, Xing K, Luan J, Han J. Stem Cell Res. 2020 Mar;43:101712. doi: 10.1016/j.scr.2020.101712. Epub 2020 Jan 17. PubMed |
| Establishment of a human induced pluripotent stem cell line (CSUASOi005-A), from peripheral blood mononuclear cells of a patient with X-linked juvenile retinoschisis carrying a novel mutation in RS1 gene. Mao S, Ding C, Zhou Y, Jing Y, Chen J, Guo Y, Liu J, Cui Z, Yan X, Gu J, Wang Y, Chen J, Tang S. Stem Cell Res. 2020 Mar;43:101718. doi: 10.1016/j.scr.2020.101718. Epub 2020 Feb 4. PubMed |
| Generation of human induced pluripotent stem cell line (WMUi001-A) from a patient with aortic dissection. Jin P, Wang S, Jiang X, Shan X, Jiang S, Quan Y, Zhang T, Yang J, Zhang H, Ma J, Dong M, Fan J, Fan X, Gong Y, Wang Y. Stem Cell Res. 2020 Mar;43:101730. doi: 10.1016/j.scr.2020.101730. Epub 2020 Feb 6. PubMed |
| Establishment of an iPSC line (JTUi002-A) from a patient with Waardenburg syndrome caused by a SOX10 mutation and carrying a GJB2 mutation. Wang P, Wang J, Xing Y, Wang H, Yu D, Feng Y, Wu H, Wu Y, Chen Z, Wang J, Shi H. Stem Cell Res. 2020 Apr;44:101756. doi: 10.1016/j.scr.2020.101756. Epub 2020 Mar 7. PubMed |
| Establishment of induced pluripotent stem cell line CSUASOi003- A from an autosomal recessive retinitis pigmentosa patient carrying compound heterozygous mutations in CRB1 gene. Zhou Y, Ding C, Xia S, Jing Y, Mao S, Liu J, Chen J, Chan HF, Tang S, Chen J. Stem Cell Res. 2020 Apr;44:101742. doi: 10.1016/j.scr.2020.101742. Epub 2020 Feb 21. PubMed |
| Establishment of an induced pluripotent stem cell line from a patient with CHARGE syndrome carrying a CHD7 (p.L1151Gfs*17) mutation. He S, Hu J, Zheng Z, Wang J, Chen J, Zhang C, Li L, Wang J, Chen Z, Shi H, Wang J. Stem Cell Res. 2020 May;45:101774. doi: 10.1016/j.scr.2020.101774. Epub 2020 Mar 20. PubMed |
| Establishment of induced pluripotent stem cell line CSUASOi004-A by reprogramming peripheral blood mononuclear cells of a PRPF6-related dominant retinitis pigmentosa patient. Zhou Y, Jing Y, Mao S, Liu J, Cui Z, Wang Y, Chen J, Chan HF, Tang S, Chen J. Stem Cell Res. 2020 May;45:101793. doi: 10.1016/j.scr.2020.101793. Epub 2020 Apr 20. PubMed |
| Generation and characterization of HLA-universal platelets derived from induced pluripotent stem cells. Norbnop P, Ingrungruanglert P, Israsena N, Suphapeetiporn K, Shotelersuk V. Sci Rep. 2020 May 21;10(1):8472. doi: 10.1038/s41598-020-65577-x. PubMed |
| Generation of twenty four induced pluripotent stem cell lines from twenty four members of the Lothian Birth Cohort 1936. Toombs J, Panther L, Ornelas L, Liu C, Gomez E, Martin-Ibanez R, Cox SR, Ritchie SJ, Harris SE, Taylor A, Redmond P, Russ TC, Murphy L, Cooper JD, Burr K, Selvaraj BT, Browne C, Svendsen CN, Cowley SA, Deary IJ, Chandran S, Spires-Jones TL, Sareen D. Stem Cell Res. 2020 Jul;46:101851. doi: 10.1016/j.scr.2020.101851. Epub 2020 May 20. PubMed |
| Characterization of an induced pluripotent stem cell line (IMBPASi001-A) derived from fibroblasts of a patient affected by Wolfram Syndrome. Grzela DP, Marciniak B, Pulaski L. Stem Cell Res. 2020 Jul;46:101858. doi: 10.1016/j.scr.2020.101858. Epub 2020 Jun 1. PubMed |
| Generation and characterization of iPSC lines (BGUi004-A, BGUi005-A) from two identical twins with polyalanine expansion in the paired-like homeobox 2B (PHOX2B) gene. Falik D, Rabinski T, Zlotnik D, Eshel R, Zorsky M, Garin-Shkolnik T, Ofir R, Adato A, Ashkenazi A, Vatine GD. Stem Cell Res. 2020 Oct;48:101955. doi: 10.1016/j.scr.2020.101955. Epub 2020 Aug 14. PubMed |
| Robust differentiation of human pluripotent stem cells into endothelial cells via temporal modulation of ETV2 with modified mRNA. Wang K, Lin RZ, Hong X, Ng AH, Lee CN, Neumeyer J, Wang G, Wang X, Ma M, Pu WT, Church GM, Melero-Martin JM. Sci Adv. 2020 Jul 24;6(30):eaba7606. doi: 10.1126/sciadv.aba7606. eCollection 2020 Jul. PubMed |
| Generation of iPSC lines from two (BGUi002-A and BGUi003-A) homozygous p450 oxidoreductase-deficient patients and from one (BGUi001-A) heterozygous healthy family relative. Zlotnik D, Rabinski T, Ofir R, Hershkovitz E, Vatine GD. Stem Cell Res. 2020 Oct;48:101975. doi: 10.1016/j.scr.2020.101975. Epub 2020 Sep 1. PubMed |
| Establishment of induced pluripotent stem cell lines from a family of an ARVC patient receiving heart transplantation in infant age carrying compound heterozygous mutations in DSP gene. Xia S, Wang X, Yue P, Li Y, Zhang D. Stem Cell Res. 2020 Oct;48:101977. doi: 10.1016/j.scr.2020.101977. Epub 2020 Sep 2. PubMed |
| An epilepsy-associated ACTL6B variant captures neuronal hyperexcitability in a human induced pluripotent stem cell model. Ahn LY, Coatti GC, Liu J, Gumus E, Schaffer AE, Miranda HC. J Neurosci Res. 2021 Jan;99(1):110-123. doi: 10.1002/jnr.24747. Epub 2020 Nov 3. PubMed |
| Generation of an induced pluripotent stem cell line SMBCi010-A from a male with Multiple Osteochondroma carrying a EXT1 mutation. Cui Y, Wang J, Zhang G, Luan J, Han J. Stem Cell Res. 2020 Dec 7;50:102111. doi: 10.1016/j.scr.2020.102111. PubMed |
| Establishment of an iPSC line (CSUXHi003-A) from a patient with Waardenburg syndrome type caused by a MITF mutation. Wen J, Song J, He C, Ling J, Liu Y, Chen H, Gong W, Mei L, Feng Y. Stem Cell Res. 2021 Mar;51:102157. doi: 10.1016/j.scr.2021.102157. Epub 2021 Jan 9. PubMed |
| Reprogramming of two induced pluripotent stem cell lines from a heterozygous GRIN2D developmental and epileptic encephalopathy (DEE) patient (BGUi011-A) and from a healthy family relative (BGUi012-A). Rabinski T, Sagiv ST, Hausman-Kedem M, Fattal-Valevski A, Rubinstein M, Avraham KB, Vatine GD. Stem Cell Res. 2021 Mar;51:102178. doi: 10.1016/j.scr.2021.102178. Epub 2021 Jan 15. PubMed |
| Establishment of an iPSC line (CSUXHi004-A) from a patient with Waardenburg syndrome type I caused by a PAX3 splice mutation. Wen J, He C, Feng Y, Song J, Liu J, Liu X, Mei L, Ling J, Chen H, Liu Y. Stem Cell Res. 2021 May;53:102300. doi: 10.1016/j.scr.2021.102300. Epub 2021 Mar 18. PubMed |
| Generation of two induced pluripotent stem cell lines from blood cells of a prostate cancer patient carrying germline mutation in CHEK2. Liu R, Qian K, Xiao Y, Jiang W. Stem Cell Res. 2021 May;53:102299. doi: 10.1016/j.scr.2021.102299. Epub 2021 Mar 18. PubMed |
| Generation of two induced pluripotent stem cell lines from patients with X-linked Alport syndrome. Ma Y, Wang Z, Gao M, Liu X, Sun W, Gong Y, Sun G, Liu G. Stem Cell Res. 2021 May;53:102343. doi: 10.1016/j.scr.2021.102343. Epub 2021 Apr 17. PubMed |
| Non-viral derivation of a transgene-free induced pluripotent stem cell line from a male beagle dog. Yoshimatsu S, Edamura K, Yoshii Y, Iguchi A, Kondo H, Shibuya H, Sato T, Shiozawa S, Okano H. Stem Cell Res. 2021 May;53:102375. doi: 10.1016/j.scr.2021.102375. Epub 2021 Apr 29. PubMed |
Establishing an induced pluripotent stem cell line from neonatal common marmoset fibroblasts by an all-in-one episomal vector approach.
Yoshimatsu S, Qian E, Sato T, Yamamoto M, Ishikawa M, Okano H.
Stem Cell Res. 2021 May;53:102380. doi: 10.1016/j.scr.2021.102380. Epub 2021 Apr 30.
PubMed
Associated Plasmids |
| Episomal vector reprogramming of human umbilical cord blood natural killer cells to an induced pluripotent stem cell line MUSIi013-A. Klaihmon P, Luanpitpong S, Lorthongpanich C, Laowtammathron C, Waeteekul S, Terbto P, Issaragrisil S. Stem Cell Res. 2021 Aug;55:102472. doi: 10.1016/j.scr.2021.102472. Epub 2021 Jul 21. PubMed |
| Engineering human skin model innervated with itch sensory neuron-like cells differentiated from induced pluripotent stem cells. Guo Z, Tong CK, Jackow J, Doucet YS, Abaci HE, Zeng W, Hansen C, Hayashi R, DeLorenzo D, Rami A, Pappalardo A, Lumpkin EA, Christiano AM. Bioeng Transl Med. 2021 Aug 20;7(1):e10247. doi: 10.1002/btm2.10247. eCollection 2022 Jan. PubMed |
| Suppression of premature transcription termination leads to reduced mRNA isoform diversity and neurodegeneration. LaForce GR, Farr JS, Liu J, Akesson C, Gumus E, Pinkard O, Miranda HC, Johnson K, Sweet TJ, Ji P, Lin A, Coller J, Philippidou P, Wagner EJ, Schaffer AE. Neuron. 2022 Apr 20;110(8):1340-1357.e7. doi: 10.1016/j.neuron.2022.01.018. Epub 2022 Feb 8. PubMed |
| Experimental method for haplotype phasing across the entire length of chromosome 21 in trisomy 21 cells using a chromosome elimination technique. Wakita S, Hara M, Kitabatake Y, Kawatani K, Kurahashi H, Hashizume R. J Hum Genet. 2022 May 31. pii: 10.1038/s10038-022-01049-6. doi: 10.1038/s10038-022-01049-6. PubMed |
| Efficient embryoid-based method to improve generation of optic vesicles from human induced pluripotent stem cells. Eintracht J, Harding P, Lima Cunha D, Moosajee M. F1000Res. 2022 Mar 17;11:324. doi: 10.12688/f1000research.108829.1. eCollection 2022. PubMed |
| Herpesvirus-induced spermidine synthesis and eIF5A hypusination for viral episomal maintenance. Choi UY, Lee JJ, Park A, Jung KL, Lee SA, Choi YJ, Lee HR, Lai CJ, Eoh H, Jung JU. Cell Rep. 2022 Aug 16;40(7):111234. doi: 10.1016/j.celrep.2022.111234. PubMed |
| Establishment of fishing cat cell biobanking for sustainable conservation. Sukparangsi W, Thongphakdee A, Karoon S, Suban Na Ayuthaya N, Hengkhunthod I, Prakongkaew R, Bootsri R, Sikaeo W. Front Vet Sci. 2022 Nov 10;9:989670. doi: 10.3389/fvets.2022.989670. eCollection 2022. PubMed |
| Loss of the crumbs cell polarity complex disrupts epigenetic transcriptional control and cell cycle progression in the developing retina. Owen N, Toms M, Tian Y, Toualbi L, Richardson R, Young R, Tracey-White D, Dhami P, Beck S, Moosajee M. J Pathol. 2023 Apr;259(4):441-454. doi: 10.1002/path.6056. Epub 2023 Feb 9. PubMed |
| HiPSC-derived cardiomyocyte to model Brugada syndrome: both asymptomatic and symptomatic mutation carriers reveal increased arrhythmogenicity. Penttinen K, Prajapati C, Shah D, Rajan DK, Cherian RM, Swan H, Aalto-Setala K. BMC Cardiovasc Disord. 2023 Apr 25;23(1):208. doi: 10.1186/s12872-023-03234-7. PubMed |
| Generation of control human iPSC line INSTEMi001-A from PBMCs of a healthy Indian donor. Patlolla N, Ponnachan P, Jamora C, Abbey D. Stem Cell Res. 2023 Jun;69:103112. doi: 10.1016/j.scr.2023.103112. Epub 2023 May 4. PubMed |
| Direct haplotype-resolved 5-base HiFi sequencing for genome-wide profiling of hypermethylation outliers in a rare disease cohort. Cheung WA, Johnson AF, Rowell WJ, Farrow E, Hall R, Cohen ASA, Means JC, Zion TN, Portik DM, Saunders CT, Koseva B, Bi C, Truong TK, Schwendinger-Schreck C, Yoo B, Johnston JJ, Gibson M, Evrony G, Rizzo WB, Thiffault I, Younger ST, Curran T, Wenger AM, Grundberg E, Pastinen T. Nat Commun. 2023 May 29;14(1):3090. doi: 10.1038/s41467-023-38782-1. PubMed |
| Pluripotency-independent induction of human trophoblast stem cells from fibroblasts. Naama M, Rahamim M, Zayat V, Sebban S, Radwan A, Orzech D, Lasry R, Ifrah A, Jaber M, Sabag O, Yassen H, Khatib A, Epsztejn-Litman S, Novoselsky-Persky M, Makedonski K, Deri N, Goldman-Wohl D, Cedar H, Yagel S, Eiges R, Buganim Y. Nat Commun. 2023 Jun 8;14(1):3359. doi: 10.1038/s41467-023-39104-1. PubMed |
| Null and missense mutations of ERI1 cause a recessive phenotypic dichotomy in humans. Guo L, Salian S, Xue JY, Rath N, Rousseau J, Kim H, Ehresmann S, Moosa S, Nakagawa N, Kuroda H, Clayton-Smith J, Wang J, Wang Z, Banka S, Jackson A, Zhang YM, Wei ZJ, Huning I, Brunet T, Ohashi H, Thomas MF, Bupp C, Miyake N, Matsumoto N, Mendoza-Londono R, Costain G, Hahn G, Di Donato N, Yigit G, Yamada T, Nishimura G, Ansel KM, Wollnik B, Hrabe de Angelis M, Megarbane A, Rosenfeld JA, Heissmeyer V, Ikegawa S, Campeau PM. Am J Hum Genet. 2023 Jul 6;110(7):1068-1085. doi: 10.1016/j.ajhg.2023.06.001. Epub 2023 Jun 22. PubMed |
| In vivo tracking transplanted cardiomyocytes derived from human induced pluripotent stem cells using nuclear medicine imaging. Saito Y, Nose N, Iida T, Akazawa K, Kanno T, Fujimoto Y, Sasaki T, Akehi M, Higuchi T, Akagi S, Yoshida M, Miyoshi T, Ito H, Nakamura K. Front Cardiovasc Med. 2023 Sep 7;10:1261330. doi: 10.3389/fcvm.2023.1261330. eCollection 2023. PubMed |
| Generation of Leber congenital amaurosis, type 12 patient-specific induced pluripotent stem cell line (LVPEIi006-A), harboring a homozygous mutation in RD3. Mahato S, Maddileti S, Naik M, Kannabiran C, Jalali S, Mariappan I. Stem Cell Res. 2024 Jun;77:103380. doi: 10.1016/j.scr.2024.103380. Epub 2024 Mar 10. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.